| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-07 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.19 | 6e-07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.26 | 1e-06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-06 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.26 | 2e-06 |